Adenoma detection rate in 41,010 patients from Southwest China

Cai,Bin; Liu,Zhixian; Xu,Yansong; Wei,Weiyuan; Zhang,Sen

doi:10.3892/ol.2015.3005

Adenoma detection rate in 41,010 patients from Southwest China

Authors:
- Bin Cai
- Zhixian Liu
- Yansong Xu
- Weiyuan Wei
- Sen Zhang
View Affiliations

Affiliations: Department of Colorectal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Emergency Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China, Department of Gastrointestinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi 530021, P.R. China
Published online on: March 2, 2015 https://doi.org/10.3892/ol.2015.3005
Pages: 2073-2077
Copyright: © Cai et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Adenoma detection rate (ADR) is considered as an important predictor of the risk of interval colorectal cancer following a screening colonoscopy. a retrospective review of all the patients who underwent colonoscopy in the First Affiliated Hospital of Guangxi Medical University (Nanning, China) between 2003 and 2012 was performed, with the aim of estimating the ADR in Southwest China and determine the effects of age, gender and polyp location on ADR. Demographic information and data regarding the timing of the colonoscopy, number of polyps removed, polyp location and pathological types of polyps were collected and analyzed. The patients were grouped according to colonoscopy date, polyp location, gender and age. the χ2 test was used to compare the ADR between the different age and gender groups and the Cochran‑Armitage trend test was used to calculate the statistical significance of the ADR trend across age groups. A two‑tailed value of P<0.05 was considered to indicate statistically significant differences. a total of 41,010 patients were included, of whom 7,219 were diagnosed with at least one adenoma on pathological examination. Therefore, the ADR value of the 41,010 patients screened in the present study was 17.6%. there was a statistically significant trend of increasing ADR with increasing age in both genders (P<0.05). In addition, the ADR of male patients was significantly higher compared with that of female patients in all age groups (all P<0.05). The ADR of patients aged >50 years was significantly higher compared with that of patients aged <50 years (28.8 vs. 11.0%, respectively; P<0.05). In addition, 20% of the cases of detected adenomas occurred in the rectum, 47% in the left colon and 33% in the right colon.

View Figures

View References

1	Bond JH: Polyp guideline: diagnosis, treatment and surveillance for patients with nonfamilial colorectal polyps. The Practice Parameters Committee of the American College of Gastroenterology. Ann Intern Med. 119:836–843. 1993. View Article : Google Scholar : PubMed/NCBI
2	Fenoglio-Preiser CM and Hutter RV: Colorectal polyps: pathologic diagnosis and clinical significance. CA Cancer J Clin. 35:322–344. 1985. View Article : Google Scholar : PubMed/NCBI
3	Kaminski MF, Regula J, Kraszewska E, et al: Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med. 362:1795–1803. 2010. View Article : Google Scholar : PubMed/NCBI
4	Barret M, Boustiere C, Canard JM, et al: Société Française d'Endoscopie Digestive: Factors associated with adenoma detection rate and diagnosis of polyps and colorectal cancer during colonoscopy in France: results of a prospective, nationwide survey. PloS One. 8:e689472013. View Article : Google Scholar : PubMed/NCBI
5	Coriat R, Lecler A, Lamarque D, et al: Quality indicators for colonoscopy procedures: a prospective multicentre method for endoscopy units. PloS One. 7:e339572012. View Article : Google Scholar : PubMed/NCBI
6	Pox CP, Altenhofen L, Brenner H, Theilmeier A, Von Stillfried D and Schmiegel W: Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology. 142:1460–1467. 2012. View Article : Google Scholar : PubMed/NCBI
7	Siegel R, Ma J, Zou Z and Jemal A: Cancer statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
8	Morson B: President's address. The polyp-cancer sequence in the large bowel. Proc R Soc Med. 67:451–457. 1974.PubMed/NCBI
9	Hill MJ, Morson BC and Bussey HJ: Aetiology of adenoma-carcinoma sequence in large bowel. Lancet. 1:245–247. 1978. View Article : Google Scholar : PubMed/NCBI
10	Allen JI: Molecular biology of colon polyps and colon cancer. Semin Surg Oncol. 11:399–405. 1995. View Article : Google Scholar : PubMed/NCBI
11	Nakamura Y: The adenomatous polyposis coli gene and human cancers. J Cancer Res Clin Oncol. 121:529–534. 1995. View Article : Google Scholar : PubMed/NCBI
12	Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S and Couture J: Molecular biology of colorectal cancer. Curr Probl Cancer. 21:233–300. 1997. View Article : Google Scholar : PubMed/NCBI
13	Powell SM, Zilz N, Beazer-Barclay Y, et al: APC mutations occur early during colorectal tumorigenesis. Nature. 359:235–237. 1992. View Article : Google Scholar : PubMed/NCBI
14	Kinzler KW and Vogelstein B: Lessons from hereditary colorectal cancer. Cell. 87:159–170. 1996. View Article : Google Scholar : PubMed/NCBI
15	Yamashita N, Minamoto T, Ochiai A, Onda M and Esumi H: Frequent and characteristic K-ras activation and absence of p53 protein accumulation in aberrant crypt foci of the colon. Gastroenterology. 108:434–440. 1995. View Article : Google Scholar : PubMed/NCBI
16	Pretlow TP, Brasitus TA, Fulton NC, Cheyer C and Kaplan EL: K-ras mutations in putative preneoplastic lesions in human colon. J Nat Cancer Inst. 85:2004–2007. 1993. View Article : Google Scholar : PubMed/NCBI
17	Vogelstein B, Fearon ER, Hamilton SR, et al: Genetic alterations during colorectal-tumor development. N Engl J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
18	Fearon ER and Vogelstein B: A genetic model for colorectal tumorigenesis. Cell. 61:759–767. 1990. View Article : Google Scholar : PubMed/NCBI
19	Cho KR and Fearon ER: DCC: linking tumour suppressor genes and altered cell surface interactions in cancer? Eur J Cancer. 31A:1055–1060. 1995. View Article : Google Scholar : PubMed/NCBI
20	Chang SC, Lin JK, Lin TC and Liang WY: Loss of heterozygosity: an independent prognostic factor of colorectal cancer. World J Gastroenterol. 11:778–784. 2005. View Article : Google Scholar : PubMed/NCBI
21	Wang W, Li YF, Sun XW, et al: Correlation analysis between loss of heterozygosity at chromosome 18q and prognosis in the stage-II colon cancer patients. Chin J Cancer. 29:761–767. 2010. View Article : Google Scholar : PubMed/NCBI
22	Baker SJ, Fearon ER, Nigro JM, et al: Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science. 244:217–221. 1989. View Article : Google Scholar : PubMed/NCBI
23	Levin B, Lieberman DA, McFarland B, et al: American College of Radiology Colon Cancer Committee: Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer and the American College of Radiology. Gastroenterology. 134:1570–1595. 2008. View Article : Google Scholar : PubMed/NCBI
24	Ferlitsch M, Reinhart K, Pramhas S, et al: Sex-specific prevalence of adenomas, advanced adenomas and colorectal cancer in individuals undergoing screening colonoscopy. JAMA. 306:1352–1358. 2011. View Article : Google Scholar : PubMed/NCBI
25	Sung JJ, Lau JY, Young GP, et al: Asia Pacific Working Group on Colorectal Cancer: Asia Pacific consensus recommendations for colorectal cancer screening. Gut. 57:1166–1176. 2008. View Article : Google Scholar : PubMed/NCBI
26	Regula J, Rupinski M, Kraszewska E, et al: Colonoscopy in colorectal-cancer screening for detection of advanced neoplasia. N Engl J Med. 355:1863–1872. 2006. View Article : Google Scholar : PubMed/NCBI
27	Chlebowski RT, Wactawski-Wende J, Ritenbaugh C, et al: Womens Health Initiative Investigators: Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med. 350:991–1004. 2004. View Article : Google Scholar : PubMed/NCBI
28	Wei EK, Colditz GA, Giovannucci EL, Fuchs CS and Rosner BA: Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study. Am J Epidemiol. 170:863–872. 2009. View Article : Google Scholar : PubMed/NCBI
29	Dominic OG, McGarrity T, Dignan M and Lengerich EJ: American College of Gastroenterology Guidelines for Colorectal Cancer Screening 2008. Am J Gastroenterol. 104:2626–2627; author reply 2628–2629. 2009. View Article : Google Scholar : PubMed/NCBI
30	Khodadoostan M, Fatemi R, Maserat E, et al: Clinical and pathological characteristics of colorectal polyps in Iranian population. East Afr J Public Health. 7:157–159. 2010.PubMed/NCBI
31	Gschwantler M, Kriwanek S, Langner E, et al: High-grade dysplasia and invasive carcinoma in colorectal adenomas: a multivariate analysis of the impact of adenoma and patient characteristics. Eur J Gastroenterol Hepatol. 14:183–188. 2002. View Article : Google Scholar : PubMed/NCBI
32	Jacobs ET, Thompson PA and Martínez ME: Diet, gender and colorectal neoplasia. J Clin Gastroenterol. 41:731–746. 2007. View Article : Google Scholar : PubMed/NCBI
33	Gupta S, Balasubramanian BA, Fu T, Genta RM, Rockey DC and Lash R: Polyps with advanced neoplasia are smaller in the right than in the left colon: implications for colorectal cancer screening. Clin Gastroenterol Hepatol. 10:1395–1401, e1392. 2012. View Article : Google Scholar : PubMed/NCBI